Fresenius | FRE - Ebitda


Fresenius reported EUR988M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Akzo Nobel EUR 388M 10M Sep/2026
Alcon AG USD 795M 478M Mar/2026
AstraZeneca USD 5.16B 510M Jun/2026
BASF EUR 1.64B 806M Sep/2026
Bayer EUR 2.14B 2.31B Jun/2026
Beiersdorf EUR 926M 58M Jun/2026
DaVita Healthcare Partners USD 746.81M 86.98M Jun/2026
Demant DKK 2.8B 47M Jun/2026
E.ON EUR 2.15B 2.97B Jun/2026
Essilor EUR 4.34B 1.25B Jun/2026
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 843.66M 19.66M Jun/2026
Getinge SEK 1.89B 1.58B Jun/2026
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GN Store Nord DKK 352M 139M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.6B 69M Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Philips EUR 910M 343M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
RWE EUR 1.38B 251M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
Smith & Nephew USD 796M 139M Dec/2025